ResMed targets sleeping giant of apnoea treatment
This article was originally published in Clinica
Executive Summary
Treatment for obstructive sleep apnoea (OSA) is the fastest growing sector of the respiratory market and is as yet largely ignored by clinicians as a preventable cause of other diseases.